DavaIndia Tolterodine 2mg Tablet

DavaIndia Tolterodine 2mg Tablet is advised to take it in a dose and duration as per prescription. It can be taken with or without food, but take it at the same time regularly. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.

Some common side effects of this medicine include dry mouth, constipation, diarrhea, and headache. Drinking plenty of water might help you cope up with the side effects. It may also make you feel dizzy or sleepy or make your vision blurry, so it advised not to drive or do anything requiring concentration until you know how it affects you. Consumption of alcohol must be avoided as it can aggravate the side effects. If any of the side effects bother you or persist, consult the doctor without delay.

Before receiving the treatment, inform your doctor if you are on any medication for any other health conditions. You should also inform your doctor if you are pregnant or breastfeeding. Patients with liver or kidney disease must be cautious while receiving the prescription and they must receive regular follow-ups as per the doctor’s advice.

Treatment of Overactive bladder (OAB) symptoms

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. DavaIndia Tolterodine 2mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

DavaIndia Tolterodine 2mg Tablet is an antimuscarinic. It works by relaxing muscles of the urinary bladder and prevents frequent, urgent or uncontrolled urination.

If you miss a dose of DavaIndia Tolterodine 2mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

DavaIndia Tolterodine 2mg Tablet treats symptoms of an overactive bladder by lowering the urge to urinate and controlling urination.

It can take up to 4 weeks before you see any improvement in your symptoms. Keep taking it as prescribed.

Avoid caffeine, alcohol, and carbonated drinks as they can worsen your symptoms.

It may cause dizziness and blurring of vision. Don’t drive or do anything that requires mental focus until you know how it affects you.

Dry mouth, dry eyes, and constipation may occur as a side effect. Maintain good oral hygiene, drink water frequently, chew sugarless gum, and wear contact lenses with caution.

Q. How long does it take for DavaIndia Tolterodine 2mg Tablet to show its effect?

Your symptoms may start improving within 1 week of starting DavaIndia Tolterodine 2mg Tablet. Maximum benefits may be seen after 5-8 weeks of treatment. To maintain this improvement, your doctor may prescribe this medicine to you for a long term of up to 24 months.

Q. What class of drug is DavaIndia Tolterodine 2mg Tablet? Is it a diuretic?

DavaIndia Tolterodine 2mg Tablet belongs to a class of medicines known as muscarinic receptor blockers. DavaIndia Tolterodine 2mg Tablet is not a diuretic, it is a urinary antispasmodic. This means that it relaxes the urinary bladder, decreasing spasm of the bladder wall. This further provides better control upon the release of urine and also increases storage volume of the bladder.

Q. Can I just stop taking DavaIndia Tolterodine 2mg Tablet?

DavaIndia Tolterodine 2mg Tablet does not cure your condition but helps to control the symptoms of overactive bladder. Do not stop taking this medicine even if you feel better. Your doctor will reassess your condition at regular intervals, like 6 months, to understand the duration for which you need to take DavaIndia Tolterodine 2mg Tablet.

Q. Can I crush the tablets of DavaIndia Tolterodine 2mg Tablet and then take it?

No, do not crush or chew the tablets. Swallow the whole tablet with a glass of water. You can take it with or without food. Take it exactly as directed by your doctor.

Q. Can DavaIndia Tolterodine 2mg Tablet be used in children?

When studied in children, DavaIndia Tolterodine 2mg Tablet did not relieve the symptoms of overactive bladder. Therefore, its use in children is not recommended.

Q. Who should avoid taking DavaIndia Tolterodine 2mg Tablet?

Patients who have urinary retention (unable to pass urine), have delayed emptying of stomach or blocked intestinal tract (toxic megacolon, ulcerative colitis, pyloric stenosis) or uncontrolled high pressure in the eyes (narrow-angle glaucoma). It should also be avoided by patients who have any muscle disease which causes drooping eyelids, double vision, difficulty in speaking and swallowing, and sometimes muscle weakness in the arms or legs (myasthenia gravis). Patients who are hypersensitive to Tolterodine should avoid it as well.

Q. I am having constipation because of which I want to discontinue DavaIndia Tolterodine 2mg Tablet. Will I have any harmful effects?

No, discontinuing DavaIndia Tolterodine 2mg Tablet will not have any harmful effects, but the symptoms of overactive bladder may return. Talk to your doctor regarding constipation and you can stop the medicine if advised by the doctor.

Q. Does DavaIndia Tolterodine 2mg Tablet cause dementia?

It is unclear whether DavaIndia Tolterodine 2mg Tablet can cause dementia or not. However, according to some reports, when people with dementia were given DavaIndia Tolterodine 2mg Tablet, their symptoms (confusion, disorientation and delusion) became worse.

In Treatment of Overactive bladder (OAB) symptoms

DavaIndia Tolterodine 2mg Tablet helps to treat uncontrollable contractions (spasms) of the bladder muscles that causes frequent urination, urgent need to urinate, and inability to control passing of urine. It also relieves painful, or frequent urination and reduces urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Diarrhea

Blurred vision

Sleepiness

Dizziness

Headache

Constipation

Dryness in mouth

Alcohol:UNSAFE

DavaIndia Tolterodine 2mg Tablet may cause excessive drowsiness with alcohol.

Pregnancy:CONSULT YOUR DOCTOR

DavaIndia Tolterodine 2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding:SAFE IF PRESCRIBED

DavaIndia Tolterodine 2mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.Long-term use of DavaIndia Tolterodine 2mg Tablet might reduce milk production.

Driving:UNSAFE

DavaIndia Tolterodine 2mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney:CAUTION

DavaIndia Tolterodine 2mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of DavaIndia Tolterodine 2mg Tablet may be needed. Please consult your doctor.

Liver:CAUTION

DavaIndia Tolterodine 2mg Tablet should be used with caution in patients with liver disease. Dose adjustment of DavaIndia Tolterodine 2mg Tablet may be needed. Please consult your doctor.

Brown JH, Laiken N. Muscarinic Receptor Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 231-32.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1379.

Tolterodine. Sandwich, Kent: Pfizer Limited; 2018. view

Tolerodine. Winchester, Kentucky: International Processing Corporation; 2004. view

Central Drugs Standard Control Organisation . view